These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8650414

  • 1. [Inhaled nitric oxide test for patients with stable chronic obstructive pulmonary disease: value and feasibility].
    Bello N, Saulnier F, Drault JN, Onimus T, Pruvot FR, Lafitte JJ, Durocher A, Wattel F.
    Rev Mal Respir; 1996; 13(1):37-42. PubMed ID: 8650414
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S, Samoyeau R, Weitzenblum E.
    Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA, Schnickel G, Ross D, Bastani S, Laks H, Esmailian F, Marelli D, Beygui R, Shemin R, Watson L, Vartapetian I, Ardehali A.
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
    [Abstract] [Full Text] [Related]

  • 8. Low doses of inhaled nitric oxide in heart transplant recipients.
    Auler Júnior JO, Carmona MJ, Bocchi EA, Bacal F, Fiorelli AI, Stolf NA, Jatene AD.
    J Heart Lung Transplant; 1996 May; 15(5):443-50. PubMed ID: 8771498
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhaled nitric oxide reduction in systolic pulmonary artery pressure is less in patients with decreased left ventricular ejection fraction.
    Cujec B, Hurst T, McCuaig R, Antecol D, Mayers I, Johnson D.
    Can J Cardiol; 1997 Sep; 13(9):816-24. PubMed ID: 9343030
    [Abstract] [Full Text] [Related]

  • 14. Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension.
    Girard C, Fargnoli JM, Godin-Ribuot D, Dutheil V, Maitrasse B, Girardet P, Arvieux CC.
    J Heart Lung Transplant; 1996 Jul; 15(7):700-8. PubMed ID: 8820786
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhaled nitric oxide does not improve cardiac or pulmonary function in patients with an exacerbation of chronic obstructive pulmonary disease.
    Baigorri F, Joseph D, Artigas A, Blanch L.
    Crit Care Med; 1999 Oct; 27(10):2153-8. PubMed ID: 10548198
    [Abstract] [Full Text] [Related]

  • 19. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K, Sbraga F, Bianco G, Speziale G, Gucciardo M, Sampognaro R, Ruvolo G.
    J Card Surg; 2005 Oct; 20(2):171-6. PubMed ID: 15725144
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.